Cargando…

Health‐related quality of life in cutaneous T‐cell lymphoma: A cross‐sectional survey study

BACKGROUND: Patients with cutaneous T‐cell lymphoma (CTCL) often have indolent but symptomatic disease. OBJECTIVE: Assessment of the health‐related quality of life (HRQoL) of patients with CTCL. METHODS: Cross‐sectional survey study. HRQoL was measured by Skindex‐16 and FACT‐G. RESULTS: A total of 3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shinohara, M.M., Mahurin, H.M., Tarabadkar, E., Hippe, D.S., Lachance, K., Kim, E.J., Loggers, E.T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060149/ https://www.ncbi.nlm.nih.gov/pubmed/35663135 http://dx.doi.org/10.1002/ski2.45

Ejemplares similares

Gender disparities in health-related quality of life (HRQoL) in patients with cutaneous T-cell lymphoma
por: Chalaka, Christopher W., et al.
Publicado: (2023)

Skin Directed Therapy in Cutaneous T-Cell Lymphoma
por: Tarabadkar, Erica S., et al.
Publicado: (2019)

Mechlorethamine Hydrochloride Gel in the Treatment of Mycosis Fungoides–Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Focus on Patient Selection and Special Considerations
por: Crimp, Caitlin, et al.
Publicado: (2022)

Sexual harassment from patient to medical student: a cross-sectional survey
por: Mahurin, Heather M., et al.
Publicado: (2022)

Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator
por: Ottevanger, Rosanne, et al.
Publicado: (2022)

United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic
por: Zic, John A., et al.
Publicado: (2020)

Quality of Life in Cutaneous T-cell Lymphoma Patients Receiving Mogamulizumab: Important Factors to Consider
por: Ottevanger, Rosanne, et al.
Publicado: (2022)

Reply to Correspondence to “Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator”
por: Ottevanger, Rosanne, et al.
Publicado: (2022)

Prevalence of sexual harassment and sexual assault from patient to provider among women in dermatology and across specialties
por: Notaro, Eliza, et al.
Publicado: (2020)

Unveiling the hidden struggles: Exploring the profound impact of advanced stage cutaneous T‐cell lymphoma on quality of life
por: Ottevanger, Rosanne, et al.
Publicado: (2023)

Epidemiology of cutaneous lymphoma
por: Vermeer, M.
Publicado: (2021)

Anaplastic Lymphoma Kinase in Cutaneous Malignancies
por: Cao, Severine, et al.
Publicado: (2017)

Editorial: Cutaneous T-Cell Lymphomas
por: Chung, Catherine G., et al.
Publicado: (2021)

Cutaneous leishmaniasis mimicking cutaneous lymphoma
por: Pires, Carla Andréa Avelar, et al.
Publicado: (2019)

Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument
por: McCaffrey, Stacey, et al.
Publicado: (2019)

Understanding itch in cutaneous T-cell lymphoma: Exploring the impact of comorbidities, treatment regimens, and racial differences on quality of life
por: Joshi, Tejas P., et al.
Publicado: (2022)

International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study
por: Geskin, Larisa J., et al.
Publicado: (2023)

Cutaneous Hodgkin's lymphoma
por: Ambekar, Asawari Anant, et al.
Publicado: (2017)

Cutaneous T-cell lymphoma
por: Arora, Shalabh, et al.
Publicado: (2020)

Ibrutinib response in cutaneous transformed lymphoplasmacytic lymphoma
por: Lindholm, Kaleigh E., et al.
Publicado: (2021)

Recurrent Bacterial Infections in Cutaneous T-cell Lymphoma
por: Adithya Sateesh, Bharadwaj, et al.
Publicado: (2022)

Primary cutaneous T‐follicular helper lymphoma
por: Fenu, Elena M., et al.
Publicado: (2023)

Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden
por: Nappi, Rossella E., et al.
Publicado: (2021)

The End-of-Life Experience of Patients With Rare Cancers and Their Caregivers
por: Loggers, Elizabeth Trice, et al.
Publicado: (2014)

Pyoderma gangrenosum in a patient with cutaneous T-cell lymphoma
por: Tang, Randy, et al.
Publicado: (2015)

TOX expression in cutaneous B-cell lymphomas
por: Schrader, Anne M. R., et al.
Publicado: (2016)

Successful treatment of cutaneous adult T-cell leukemia/lymphoma with imiquimod
por: Messer, Alison, et al.
Publicado: (2019)

Genomic landscape of cutaneous T cell lymphoma
por: Choi, Jaehyuk, et al.
Publicado: (2015)

Italian Real-Life Experience on the Use of Mogamulizumab in Patients with Cutaneous T-Cell Lymphomas
por: Caruso, Laura, et al.
Publicado: (2022)

Quality of life in women with endometriosis: a cross-sectional survey
por: Bień, Agnieszka, et al.
Publicado: (2020)

Pathologic characteristics of primary cutaneous T-cell lymphoma in Korea.
por: Kim, J. E., et al.
Publicado: (1998)

Phase II Evaluation of VDC‐1101 in Canine Cutaneous T‐Cell Lymphoma
por: Morges, M.A., et al.
Publicado: (2014)

International Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of CTCL outcomes during COVID-19
por: Geskin, Larisa J, et al.
Publicado: (2021)

A Literature Revision in Primary Cutaneous B-cell Lymphoma
por: Selva, R La, et al.
Publicado: (2017)

Dermatophytosis Incognito Mimicking Cutaneous T-Cell Lymphoma
por: Babakoohi, Shahab, et al.
Publicado: (2022)

Imaging Cutaneous T-Cell Lymphoma with Optical Coherence Tomography
por: Ring, Hans Christian, et al.
Publicado: (2012)

Ultraviolet radiation and cutaneous lymphoma.
por: Zackheim, H.
Publicado: (1998)

Cutaneous T-Cell Lymphoma in Asians
por: Jang, Min Soo, et al.
Publicado: (2012)

An overview of cutaneous T cell lymphomas
por: Bagherani, Nooshin, et al.
Publicado: (2016)

Immunomodulation in Cutaneous T Cell Lymphoma
por: Ferranti, Martina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2nr7v6lb6hk5u2h4rn325s4s63